Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
120 participants
INTERVENTIONAL
2007-07-31
2009-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Safety and Efficacy of Sahasthara ME vs Diclofenac ME for Treating Primary Knee Osteoarthritis
NCT06184685
A Long-Term Safety Study of IDEA-033 in Comparison to Oral Naproxen for the Treatment of Osteoarthritis of the Knee
NCT00265304
Ibuprofen Gel or Capsaicin Cream for my Painful Knee Osteoarthritis?
NCT03146689
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Knee
NCT00504127
Efficacy Study on Symptomatic Control of Patient With Knee Osteoarthritis Between 0.0125% of Capsaicin to Placebo
NCT00471055
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
naproxen
Naproxen 500 mg/day for 4 weeks
naproxen
Naproxen 500 mg/day for 4 weeks
Derris Scandens Benth
Derris Scandens Benth
Derris scandens Benth extracts
Derris scandens Benth extracts (oral) 400 mg twice per day for 4 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Derris scandens Benth extracts
Derris scandens Benth extracts (oral) 400 mg twice per day for 4 weeks
naproxen
Naproxen 500 mg/day for 4 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Known case of primary knee osteoarthritis
* WOMAC pain subscale (item1) \>= 5
* signed informed consent
Exclusion Criteria
* history of peptic ulcer or melena
* unable to walk , i.e. patient with severe spinal stenosis, myocardial infarction
* history of intra-articular injection of knee within 3 months
* status post knee replacement
50 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ministry of Health, Thailand
OTHER_GOV
Mahidol University
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Vilai Kuptniratsaikul, Assoc.Prof.
Role: PRINCIPAL_INVESTIGATOR
Department of Rehabilitation Medicine, Faculty of Medicine Siriraj Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Siriraj Hospital
Bangkoknoi, Bangkok, Thailand
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Siriraj CEU 50-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.